6Z48 image
Deposition Date 2020-05-23
Release Date 2022-06-01
Last Version Date 2024-11-13
Entry Detail
PDB ID:
6Z48
Keywords:
Title:
Crystal structure of Thrombin in complex with macrocycle X1vE
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.27 Å
R-Value Free:
0.24
R-Value Work:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Thrombin heavy chain
Gene (Uniprot):F2
Chain IDs:B (auth: H), D (auth: B), F (auth: D), H (auth: F)
Chain Length:259
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Thrombin light chain
Gene (Uniprot):F2
Chain IDs:A (auth: L), C (auth: A), E (auth: C), G (auth: E)
Chain Length:36
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale.
Nat Commun 13 3823 3823 (2022)
PMID: 35780129 DOI: 10.1038/s41467-022-31428-8

Abstact

Macrocycles have excellent potential as therapeutics due to their ability to bind challenging targets. However, generating macrocycles against new targets is hindered by a lack of large macrocycle libraries for high-throughput screening. To overcome this, we herein established a combinatorial approach by tethering a myriad of chemical fragments to peripheral groups of structurally diverse macrocyclic scaffolds in a combinatorial fashion, all at a picomole scale in nanoliter volumes using acoustic droplet ejection technology. In a proof-of-concept, we generate a target-tailored library of 19,968 macrocycles by conjugating 104 carboxylic-acid fragments to 192 macrocyclic scaffolds. The high reaction efficiency and small number of side products of the acylation reactions allowed direct assay without purification and thus a large throughput. In screens, we identify nanomolar inhibitors against thrombin (Ki = 44 ± 1 nM) and the MDM2:p53 protein-protein interaction (Kd MDM2 = 43 ± 18 nM). The increased efficiency of macrocycle synthesis and screening and general applicability of this approach unlocks possibilities for generating leads against any protein target.

Legend

Protein

Chemical

Disease

Primary Citation of related structures